Wings Magazine

News
Aéroports de Montréal to build new facility for Aerolia

Oct. 3, 2013, Montreal - During a cornerstone-laying ceremony held today at Montréal-Mirabel International Airport, Aéroports de Montréal (ADM) announced that it will invest $9.5 million in a new custom-built facility for leading French aerostructure firm Aerolia.


October 3, 2013  By Carey Fredericks

The firm, a member of the EADS Group, will use the facility to
produce the equipped centre fuselage for Bombardier's Global 7000 and
8000 business jets.

 

"Aéroports de Montréal offered to provide Aerolia with a
turnkey facility to help the company establish its operations in Québec.
In addition to the site's inherent advantages, the offer was
instrumental in Aerolia's decision to open its first North American
factory in Montréal-Mirabel's industrial park," said Henri-Paul Martel,
Vice-President, Planning, Engineering and Construction, ADM.

 

Advertisement

Aerolia will lease the facility under an initial 15-year
agreement, with the option to renew for three further five-year periods.
With a surface area of 7,300 square metres, the building will house the
head office of Aerolia's Canadian subsidiary, as well as manufacturing
workshops, a warehouse and logistics area.

 

ADM has commissioned Syscomax Construction, a Québec
contractor with a well-established record at Mirabel, to complete the
project according to the design-build model. This model was favoured
over the traditional sequential model, primarily to save time. The
facility is expected to be completed by early

February 2014. In addition
to financing the project, ADM will oversee quality control and
workplace safety during construction on the site.

 

Aerolia's move to Montréal-Mirabel will create some 150 jobs
at the airport and strengthen its position as a world-class aerospace
hub. Montréal-Mirabel is already home to a number of major aerospace
industry players, including Bombardier Aerospace, Pratt & Whitney,
L-3 MAS, Mecachrome, Safran, Avianor et Nolinor.

Advertisement

Stories continue below